NASDAQ: GERNGeron Corp Stock Ownership - Who owns Geron?
Insider buying vs selling
Have Geron Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert J. Spiegel | Director | 2025-03-31 | 4,913 | $1.59 | $7.81kBuy |
| Scott Alan Samuels | EVP Chief Legal Officer | 2025-02-27 | 15,000 | $1.61 | $24.15kBuy |
| James Ziegler | EVP Chief Commercial Officer | 2025-02-27 | 100,000 | $1.60 | $160.00kBuy |
| John A. Scarlett | Chairman President and CEO | 2025-02-27 | 12,500 | $1.77 | $22.06kBuy |
| Robert J. Spiegel | Director | 2024-12-31 | 2,206 | $3.54 | $7.81kBuy |
| Robert J. Spiegel | Director | 2024-09-30 | 1,767 | $4.54 | $8.02kBuy |
| Andrew J. Grethlein | EVP Chief Operating Officer | 2024-07-08 | 674,348 | $4.56 | $3.07MSell |
| Andrew J. Grethlein | EVP Chief Operating Officer | 2024-07-08 | 674,348 | $1.72 | $1.16MBuy |
| Robert J. Spiegel | Director | 2024-06-28 | 1,916 | $4.24 | $8.12kBuy |
| Faye Feller | EVP Chief Medical Officer | 2024-06-10 | 287,900 | $4.63 | $1.33MSell |
GERN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GERN insiders and whales buy or sell their stock.
GERN Shareholders
What type of owners hold Geron Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 7.83% | 49,857,761 | $69.80M | Institution |
| Vanguard Group Inc | 5.27% | 33,538,822 | $46.95M | Institution |
| Ra Capital Management LP | 4.71% | 30,009,536 | $42.01M | Institution |
| Vivo Capital LLC | 4.27% | 27,225,292 | $38.12M | Institution |
| State Street Corp | 4.26% | 27,158,191 | $38.02M | Institution |
| Janus Henderson Group PLC | 4.25% | 27,082,461 | $37.92M | Institution |
| Holocene Advisors LP | 3.48% | 22,195,909 | $31.07M | Institution |
| Adage Capital Partners GP LLC | 3.42% | 21,800,000 | $30.52M | Institution |
| Fmr LLC | 2.25% | 14,332,783 | $20.07M | Institution |
| Goldman Sachs Group Inc | 2.14% | 13,610,151 | $19.05M | Institution |
GERN vs Biotech Stocks
Geron Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.